Here are four quick points:
1. Medtronic lost 0.71 percent in the last trading session.
2. Eight analysts rated the stock as “buy,” 12 rated it as “outperform” and five rated is as “hold.”
3. Analysts gave a consensus estimate of $1.27 per share.
4. Wall Street analysts predict Medtronic will have earnings of $4.37 per share for the full year.
5. Analysts anticipate Medtronic will keep an annual growth of 6.43 percent over the next five years.
More articles on devices:
DJO Global 2015 net sales hit $308M; Net loss hits $349.9M: 8 things to know
Mesoblast’s Mesenchymal Precursor Cells receives key patent — 5 takeaways
SpineGuard announces full-year 2015 financial results: 9 facts
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
